Kawasaki Disease: Effect of Treatment on Coronary Artery Involvement
- 1 February 1979
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 63 (2) , 175-179
- https://doi.org/10.1542/peds.63.2.175
Abstract
Ninety-two patients with Kawasaki disease were treated with five different types of drug therapy: a steroid preparation (prednisolone), aspirin, an antibiotic, a combination of steroid plus aspirin, and a combination of steroid plus warfarin. One to two months after the onset of the disease, coronary angiography demonstrated coronary aneurysms in 20% of cases treated with an antibiotic alone, 64.7% of cases in the steroid-treated group, and 11% of those in the aspirin-treated group. These findings suggest that the steroid might act adversely to cause a progression of coronary lesions of the disease. The aspirin-treated group did not have a significantly lower incidence of coronary lesions compared with the group treated with an antibiotic alone. But in view of the fact that the direct cause of sudden death of the disease is thrombotic occlusion of a coronary artery, aspirin might act as the effective means for prevention of sudden death due to Kawasaki disease.This publication has 3 references indexed in Scilit:
- Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in KoreaKorean Circulation Journal, 2019
- Are Infantile Periarteritis Nodosa With Coronary Artery Involvement and Fatal Mucocutaneous Lymph Node Syndrome the Same? Comparison of 20 Patients From North America With Patients From Hawaii and JapanPediatrics, 1977
- THE RELATIONSHIP OF THERAPY WITH CORTISONE TO THE INCIDENCE OF VASCULAR LESIONS IN RHEUMATOID ARTHRITISAnnals of Internal Medicine, 1957